Qualitative study exploring the feasibility, usability and acceptability of neonatal continuous monitoring technologies at a public tertiary hospital in Nairobi, Kenya

Abstract

ObjectiveTo assess the feasibility, usability and acceptability of two non-invasive, multiparameter, continuous physiological monitoring (MCPM) technologies for use in neonates within a resource-constrained healthcare setting in sub-Saharan Africa.DesignA qualitative study using in-depth interviews and direct observations to describe healthcare professional and caregiver perspectives and experiences with investigational MCPM technologies from EarlySense and Sibel compared with selected reference technologies.SettingPumwani Maternity Hospital is a public, high-volume, tertiary hospital in Nairobi, Kenya.ParticipantsIn-depth interviews were conducted with five healthcare administrators, 12 healthcare providers and 10 caregivers. Direct observations were made of healthcare providers using the technologies on 12 neonates overall.ResultsDesign factors like non-invasiveness, portability, ease-of-use and ability to measure multiple vital signs concurrently emerged as key themes supporting the usability and acceptability of the investigational technologies. However, respondents also reported feasibility challenges to implementation, including overcrowding in the neonatal unit, lack of reliable access to electricity and computers, and concerns about cost and maintenance needs. To improve acceptability, respondents highlighted the need for adequate staffing to appropriately engage caregivers and dispel misconceptions about the technologies.ConclusionStudy participants were positive about the usefulness of the investigational technologies to strengthen clinical care quality and identification of at-risk neonates for better access to timely interventions. These technologies have the potential to improve equity of access to appropriate healthcare services and neonatal outcomes in sub-Saharan African healthcare facilities. However, health system strengthening is also critical to support sustainable uptake of technologies into routine care.Trial registration numberNCT03920761.

Feasibility, performance and acceptability of an innovative vital signs monitor for sick newborns in Western Kenya: A mixed-methods study

“…Medical staff caring for the newborns also expressed a high level of acceptability of the product, which is consistent with similar studies on the feasibility, acceptability and implementation of other wearable vital signs monitors. 20 , 21 , 26 , 27 Users surveyed highlighted neoGuard's simplicity to learn, ease of use and ability to measure multiple parameters concurrently as the most positive features of the technology, and they emphasized the importance of adequate user training for successful adoption. Conversely, respondents cited respiratory rate accuracy and device placement as parameters that could be improved upon to optimize performance and increase user preference for the neoGuard technology.…”

Clinical feasibility of an advanced neonatal epidermal multiparameter continuous monitoring technology in a large public maternity hospital in Nairobi, Kenya

“…The projected cost of commercial acquisition of Sibel’s reusable and rechargeable technology is about $40USD with an additional $0.20USD per unit for adhesives/consumables lasting 24 to 72 h. In a previous clinical trial of neonates in Kenya, we evaluated the accuracy of ANNE to measure HR, RR, SpO 2 , and temperature when compared to verified reference technologies 7 . We also completed qualitative assessments of the feasibility, usability, and acceptability among healthcare personnel and caregivers by conducting in-depth interviews and observations 8 , 9 .…”